FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy
Open Access
- 1 January 2012
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 3, 241-245
Abstract
Purpose: Talc pleurodesis (TP) is employed worldwide for the management of persistent pneumothorax or pleural effusion, particularly of malignant origin. However, there are very little available data on 18F-fluorodeoxyglucose positron-emission tomography/computed tomography (18F FDG PET/CT) response evaluation in malignant pleural mesothelioma (MPM) patients treated with TP and chemotherapy.Keywords
This publication has 25 references indexed in Scilit:
- Pleural FDG Uptake More Than a Decade after Talc PleurodesisCase Reports in Medicine, 2009
- False positive 18F-FDG-PET/CT in a patient after talc pleurodesisLung Cancer, 2007
- Positron emission tomography staging of pleural deposits following Monaldi's procedure: an accurate reflection or a false staging?Interactive CardioVascular and Thoracic Surgery, 2006
- Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.2003
- Talc pleurodesis: a matter of priority.American Journal of Roentgenology, 1997
- Pleurodesis: state of the artEuropean Respiratory Journal, 1997
- Evaluation of pleural diseases with FDG-PET imaging: preliminary reportThorax, 1997
- Talc pleurodesis simulating pleural metastases on 18F-fluorodeoxyglucose positron emission tomography.American Journal of Roentgenology, 1997
- Talc Pleurodesis for the Treatment of Pneumothorax and Pleural EffusionChest, 1994
- Talc pleurodesis. Experience with 360 patients.1993